BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

619 related articles for article (PubMed ID: 11030354)

  • 1. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization.
    Schlessinger J; Plotnikov AN; Ibrahimi OA; Eliseenkova AV; Yeh BK; Yayon A; Linhardt RJ; Mohammadi M
    Mol Cell; 2000 Sep; 6(3):743-50. PubMed ID: 11030354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for activation of fibroblast growth factor signaling by sucrose octasulfate.
    Yeh BK; Eliseenkova AV; Plotnikov AN; Green D; Pinnell J; Polat T; Gritli-Linde A; Linhardt RJ; Mohammadi M
    Mol Cell Biol; 2002 Oct; 22(20):7184-92. PubMed ID: 12242295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization.
    Ibrahimi OA; Yeh BK; Eliseenkova AV; Zhang F; Olsen SK; Igarashi M; Aaronson SA; Linhardt RJ; Mohammadi M
    Mol Cell Biol; 2005 Jan; 25(2):671-84. PubMed ID: 15632068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly.
    Ibrahimi OA; Zhang F; Hrstka SC; Mohammadi M; Linhardt RJ
    Biochemistry; 2004 Apr; 43(16):4724-30. PubMed ID: 15096041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dimeric ternary complex of FGFR [correction of FGFR1], heparin and FGF-1 leads to an 'electrostatic sandwich' model for heparin binding.
    Huhtala MT; Pentikäinen OT; Johnson MS
    Structure; 1999 Jun; 7(6):699-709. PubMed ID: 10404599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex.
    Venkataraman G; Raman R; Sasisekharan V; Sasisekharan R
    Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3658-63. PubMed ID: 10097093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradigms in the structural biology of the mitogenic ternary complex FGF:FGFR:heparin.
    Pomin VH
    Biochimie; 2016 Aug; 127():214-26. PubMed ID: 27263122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for fibroblast growth factor receptor activation.
    Mohammadi M; Olsen SK; Ibrahimi OA
    Cytokine Growth Factor Rev; 2005 Apr; 16(2):107-37. PubMed ID: 15863029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes.
    Ostrovsky O; Berman B; Gallagher J; Mulloy B; Fernig DG; Delehedde M; Ron D
    J Biol Chem; 2002 Jan; 277(4):2444-53. PubMed ID: 11714710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A protein canyon in the FGF-FGF receptor dimer selects from an à la carte menu of heparan sulfate motifs.
    Mohammadi M; Olsen SK; Goetz R
    Curr Opin Struct Biol; 2005 Oct; 15(5):506-16. PubMed ID: 16154740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence analyses and comparative modeling of fly and worm fibroblast growth factor receptors indicate that the determinants for FGF and heparin binding are retained in evolution.
    Nagendra HG; Harrington AE; Harmer NJ; Pellegrini L; Blundell TL; Burke DF
    FEBS Lett; 2001 Jul; 501(1):51-8. PubMed ID: 11457455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin.
    Pellegrini L; Burke DF; von Delft F; Mulloy B; Blundell TL
    Nature; 2000 Oct; 407(6807):1029-34. PubMed ID: 11069186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common and specific determinants for fibroblast growth factors in the ectodomain of the receptor kinase complex.
    Wang F; Lu W; McKeehan K; Mohamedali K; Gabriel JL; Kan M; McKeehan WL
    Biochemistry; 1999 Jan; 38(1):160-71. PubMed ID: 9890894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diversity does make a difference: fibroblast growth factor-heparin interactions.
    Faham S; Linhardt RJ; Rees DC
    Curr Opin Struct Biol; 1998 Oct; 8(5):578-86. PubMed ID: 9818261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin modulates the mitogenic activity of fibroblast growth factor by inducing dimerization of its receptor. a 3D view by using NMR.
    Nieto L; Canales Á; Fernández IS; Santillana E; González-Corrochano R; Redondo-Horcajo M; Cañada FJ; Nieto P; Martín-Lomas M; Giménez-Gallego G; Jiménez-Barbero J
    Chembiochem; 2013 Sep; 14(14):1732-44. PubMed ID: 23940086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for FGF receptor dimerization and activation.
    Plotnikov AN; Schlessinger J; Hubbard SR; Mohammadi M
    Cell; 1999 Sep; 98(5):641-50. PubMed ID: 10490103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compositional analysis of heparin/heparan sulfate interacting with fibroblast growth factor.fibroblast growth factor receptor complexes.
    Zhang F; Zhang Z; Lin X; Beenken A; Eliseenkova AV; Mohammadi M; Linhardt RJ
    Biochemistry; 2009 Sep; 48(35):8379-86. PubMed ID: 19591432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement for anticoagulant heparan sulfate in the fibroblast growth factor receptor complex.
    McKeehan WL; Wu X; Kan M
    J Biol Chem; 1999 Jul; 274(31):21511-4. PubMed ID: 10419453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparan sulfate fibroblast growth factor receptor complex: structure-function relationships.
    McKeehan WL; Kan M
    Mol Reprod Dev; 1994 Sep; 39(1):69-81; discusison 81-2. PubMed ID: 7999363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing fibroblast growth factor dimerization and role of heparin-like glycosaminoglycans in modulating dimerization and signaling.
    Kwan CP; Venkataraman G; Shriver Z; Raman R; Liu D; Qi Y; Varticovski L; Sasisekharan R
    J Biol Chem; 2001 Jun; 276(26):23421-9. PubMed ID: 11292822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.